Locations
United States · North Carolina, USA · Durham, NC, USA · North America
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2006
Precision BioSciences is a biotechnology company focused on developing innovative gene editing therapies using its proprietary ARCUS technology. This platform enables precise modifications to DNA, allowing for potential cures for hard-to-treat genetic diseases, including chronic hepatitis B and mitochondrial disorders. The company is advancing its pipeline with clinical trials and has received FDA designations for its therapies, positioning itself as a leader in the gene editing space. With a strong team of experts and a commitment to scientific advancement, Precision BioSciences aims to transform the landscape of genetic medicine.
Something looks off?On-site & Remote